Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
G1-Dependent Prion Protein Expression in Human Glioblastoma Cell Line T98G
Yutaka KikuchiTomoshi KakeyaTakeshi YamazakiKaori TakekidaNaoto NakamuraHaruo MatsudaKosuke TakatoriAkio TanimuraKen-ichi TanamotoJun-ichi Sawada
Author information
JOURNAL FREE ACCESS

2002 Volume 25 Issue 6 Pages 728-733

Details
Abstract

Human glioblastoma cell line T98G produced a cellular form of prion protein (PrPC), and we confirmed expression of PrP mRNA by RT-PCR. Immunoblot analysis of whole cell lysate revealed one major (35 kDa) and two faint bands (31, 25 kDa) that reacted with monoclonal anti-human PrP antibody 3F4. Cells treated with tunicamycin produced only a 25 kDa band, representing a deglycosylated form of PrP. Similarly, peptide: N-glycosidase F treatment of whole cell lysate altered the Asn-linked form to the deglycosylated form. When T98G cells were cultured for a longer period, the amount of PrPC per cell increased on Day 4 to 16 in a time-dependent manner. When the cells were cultured at high cell-density, the cells on Day 4 produced the same amount of PrPC as those on Day 16 of the usual culture. Moreover, in a serum-free medium, cells cultured at a low cell-density produced the same amount of PrPC as those cultured at the high cell-density. These results demonstrate that PrPC production in T98G cells was dependent on the phase of the cell cycle, probably the G1 phase.

Content from these authors
© 2002 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top